NTCB02-1
N/A
Report date: 2024/10/09 20:00:32
NME
Base Information
Drug NameNTCB02-1
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesYuhan Corp
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A